Every number ASCEND returns — draw volume, concentration, vial yield — is verified, not estimated. Every dosing parameter in our calculator is cross-referenced against independent 3rd-party analytical laboratory batch reports, published clinical trial data, and peer-reviewed pharmacokinetic literature — then reconciled before going live.
The Three-Source Verification Process
Every peptide preset goes through a three-layer reconciliation before it is published in the calculator.
1
Clinical Trial Extraction — Starting dose, titration schedule, and vial concentration are extracted from published phase 1/2/3 clinical trial data where available (ClinicalTrials.gov, PubMed, peer-reviewed journals).
2
Independent Laboratory Cross-Reference — Batch reports from multiple independent 3rd-party analytical chemistry laboratories are reviewed to confirm actual peptide concentration, purity, and identity against labeled claims.
3
Pharmacokinetic Reconciliation — Final parameters are reconciled against published half-life, bioavailability, and route-of-administration data to ensure the dose calculator output is internally consistent.
What "Verified" Means on a Result
When you see the ✓ Verified badge on your calculation, it means the dosing logic for that peptide has passed all three verification layers. The math behind your draw volume, concentration, and vial yield has been independently confirmed — not estimated.
The Four Pillars of the ASCEND Standard
🔬
Multi-Lab Sourcing
No single lab is used as the sole authority. Batch data is compared across multiple independent laboratories.
📄
Clinical Trial Grounding
Where phase 2/3 trial data exists, it takes precedence over anecdotal or community-sourced dosing figures.
🔄
Regular Review Cycle
Presets are reviewed and updated as new batch reports and clinical data become available. Review dates are shown on each calculator page.
⚠️
Transparent Uncertainty
Where clinical data is limited, this is disclosed. No preset is presented with more confidence than the underlying evidence supports.